Parenteral nutrition support in patients with cancer.
In the patient with cancer, malnutrition may result from the disease itself or from its treatment. Total parenteral nutrition (TPN) has been used for many years to treat or prevent malnutrition in the patient with cancer. There have been few studies, however, that demonstrate significant benefit from TPN therapy in these patients. Patients receiving high-dose chemotherapy (as in bone marrow transplantation), and patients with solid tumors who have documented malnutrition (cachexia, weight loss) prior to cancer surgery, may benefit from TPN. No other groups of patients with cancer appear to derive significant benefit from TPN, and some groups may actually be harmed by its use. Practical considerations in the use of TPN include periodic calorie-protein assessment, electrolyte management, and monitoring for drug-TPN interactions.
Ignoffo
R J
RJ
Division of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco 94143.
D016026:Bone Marrow Transplantation; D002100:Cachexia / Q000209:etiology; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000378:metabolism; D009748:Nutrition Disorders / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D010289:Parenteral Nutrition, Total